Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2009 2
2010 1
2011 3
2012 1
2013 2
2014 4
2015 2
2016 3
2017 4
2018 6
2019 18
2020 13
2021 17
2022 25
2023 16
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.
Hussain M, Mateo J, Fizazi K, Saad F, Shore N, Sandhu S, Chi KN, Sartor O, Agarwal N, Olmos D, Thiery-Vuillemin A, Twardowski P, Roubaud G, Özgüroğlu M, Kang J, Burgents J, Gresty C, Corcoran C, Adelman CA, de Bono J; PROfound Trial Investigators. Hussain M, et al. N Engl J Med. 2020 Dec 10;383(24):2345-2357. doi: 10.1056/NEJMoa2022485. Epub 2020 Sep 20. N Engl J Med. 2020. PMID: 32955174 Free article. Clinical Trial.
Paraurachal paraganglioma.
Tsuruta M, Goto T, Kono J, Kita Y, Masui K, Sano T, Fujimoto M, Sawada A, Akamatsu S, Kobayashi T. Tsuruta M, et al. Among authors: goto t. IJU Case Rep. 2022 May 31;5(5):358-361. doi: 10.1002/iju5.12488. eCollection 2022 Sep. IJU Case Rep. 2022. PMID: 36090947 Free PMC article.
Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysis.
Matsubara N, Nishimura K, Kawakami S, Joung JY, Uemura H, Goto T, Kwon TG, Sugimoto M, Kato M, Wang SS, Pang ST, Chen CH, Fujita T, Nii M, Shen L, Dujka M, Hussain M, de Bono J. Matsubara N, et al. Among authors: goto t. Jpn J Clin Oncol. 2022 May 5;52(5):441-448. doi: 10.1093/jjco/hyac015. Jpn J Clin Oncol. 2022. PMID: 35229141 Free PMC article. Clinical Trial.
Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer.
Kimura H, Mizuno K, Shiota M, Narita S, Terada N, Fujimoto N, Ogura K, Hatano S, Iwasaki Y, Hakozaki N, Ishitoya S, Sumiyoshi T, Goto T, Kobayashi T, Nakagawa H, Kamoto T, Eto M, Habuchi T, Ogawa O, Momozawa Y, Akamatsu S. Kimura H, et al. Among authors: goto t. Br J Cancer. 2022 Nov;127(9):1680-1690. doi: 10.1038/s41416-022-01915-2. Epub 2022 Aug 19. Br J Cancer. 2022. PMID: 35986085 Free PMC article.
116 results